Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameRepublic HC
Stock Code08357
Company Full NameTo be extracted
IndustryHealthcare
Principal Activities我們是一家新加坡基本健康護理服務提供者,自2010年起以「Dr. Tan & Partners」名義經營全科醫療診治中心網絡,為常見病症提供治療方案,專營性健康及傳染病;2017年5月以「S Aesthetics」名義開展醫學美容診治中心業務,提供基本醫學美容服務。
Listing Date2018-06-15
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)香港灣仔灣仔道165–171號樂基中心1402室
Business Address (Hong Kong)香港皇后大道中99號中環中心57樓5705室
Place of Incorporation開曼群島
Listing Method發售以供認購 + 發售以供配售
Listing BoardGEM
Websiterepublichealthcare.asia
Share Registrar宝德隆
Registrar Contact(852)2153 1688
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism B
Offer PriceHK$ 0.60 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2018-06-01 to 2018-06-06
Global Offering Shares130,000,000 shares
HK Public Offer Shares (Initial)13,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)117,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO520,000,000 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 78,000,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 90.6M
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +10619%

Valuation & Financials

Market Cap (at Offer Price)HK$ 312,000,000
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status盈利約新加坡元2.0百萬元
Period-End Cash Balance新加坡元1,993,771
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: RMB
Income Statement
Item 20162017
Revenue 7,127,9919,956,894
Other income and gains, net 125,355101,927
Profit before tax 2,272,8082,048,001
Income tax expense -297,442-40,500
Profit for the year 1,975,3662,007,501
Profit attributable to owners 1,975,3662,007,501
Balance Sheet
Item 20162017
Cash and cash equivalents 2,064,2431,993,771
Trade and bills receivables 15,39278,038
Inventories 577,485400,448
Total current assets 2,802,5492,999,597
Total assets 3,265,7533,826,300
Total current liabilities 1,351,7042,123,246
Total liabilities 1,381,8472,127,889
Total equity 1,883,9061,698,411
Equity attributable to owners 1,883,9061,698,411
Cash Flow Statement
Item 20162017
Net cash from operating activities 1,900,9682,955,835
Net cash from investing activities -349,814-576,902
Net cash from financing activities -574,568-2,449,405
Net increase in cash 976,586-70,472
Depreciation of PP&E 144,220263,611
Purchase of PP&E -352,219-576,902
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 0.79
First Day OpenHK$ 0.65
First Day Change31.67%
First Day Volume193155000.0
First Day Turnover146948000.0
Use of Proceeds
1、約2.6百萬新加坡元或所得款項凈額約28.5%將用于策略性地拓展及鞏固DTAP診治中心的網絡; 2、約1.4百萬新加坡元或所得款項凈額約15.7%將用于增設新SA診治中心; 3、約4.3百萬新加坡元或所得款項凈額約46.9%用于持續吸納及挽留醫生和員工人才; 4、約0.6百萬新加坡元或所得款項凈額約6.4%將用于提升及改善信息科技基礎設施與系統; 5、約0.1百萬新加坡元或所得款項凈額約1.1%將用作設立中央藥庫; 6、約0.1百萬新加坡元或所得款項凈額約1.4%將用作一般營運資金。

Underwriting Syndicate

Sole Sponsor (1)
Titan Financial Services Limited CE BFR957
Joint Bookrunners (3)
CHINA INDUSTRIAL SECURITIES INTERNATIONAL CAPITAL LIMITED CE BAK956 TSE'S SECURITIES LIMITED CE ABH659 Titan Financial Services Limited CE BFR957
Joint Lead Managers (3)
CHINA INDUSTRIAL SECURITIES INTERNATIONAL CAPITAL LIMITED CE BAK956 TSE'S SECURITIES LIMITED CE ABH659 Titan Financial Services Limited CE BFR957

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman陳致暹—
Company Secretary郭兆文—
No director data available.

Major Shareholders

Major Shareholders & Holdings英屬處女群島公司2號持股390,000,000股(75%);陳醫生透過該公司持有390,000,000股(75%)權益
About this page

This page shows Republic HC (08357) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect